Search for author "A. Michael Lincoff"
297 Results
- You have accessRestricted accessAbstract 3432: Eptifibatide plus Heparin Increases the Risk of Major and Minor Hemorrhagic Complications Compared to Bivalirudin in Patients with Normal Renal Function Undergoing Percutaneous Coronary InterventionMichael C McDaniel, Reza Fazel, Michele D Voeltz, Frederick Feit, A. M Lincoff and Steven V ManoukianCirculation. 2006;114:II_731
- You have accessAbstract 3432: Eptifibatide plus Heparin Increases the Risk of Major and Minor Hemorrhagic Complications Compared to Bivalirudin in Patients with Normal Renal Function Undergoing Percutaneous Coronary InterventionMichael C McDaniel, Reza Fazel, Michele D Voeltz, Frederick Feit, A. M Lincoff, Steven V ManoukianCirculation October 2006, 114 (Suppl 18) II_731;By Michael C McDaniel, Reza Fazel, Michele D Voeltz, Frederick Feit, A. M Lincoff and Steven V Manoukian
- You have accessRestricted accessAbstract 3303: Safety and Efficacy of Bivalirudin in Patients with non-ST Elevation Acute Coronary Syndromes Undergoing Medical Management: Results from the Randomized ACUITY TrialWalter Desmet, Lars H Rasmussen, A M Lincoff, Angel R Cequier, Hans-Jürgen Rupprecht, Bernard J Gersh, Steven V Manoukian, Michel E Bertrand and Gregg W StoneCirculation. 2006;114:II_701
- You have accessAbstract 3303: Safety and Efficacy of Bivalirudin in Patients with non-ST Elevation Acute Coronary Syndromes Undergoing Medical Management: Results from the Randomized ACUITY TrialWalter Desmet, Lars H Rasmussen, A M Lincoff, Angel R Cequier, Hans-Jürgen Rupprecht, Bernard J Gersh, Steven V Manoukian, Michel E Bertrand, Gregg W StoneCirculation October 2006, 114 (Suppl 18) II_701;By Walter Desmet, Lars H Rasmussen, A M Lincoff, Angel R Cequier, Hans-Jürgen Rupprecht, Bernard J Gersh, Steven V Manoukian, Michel E Bertrand and Gregg W Stone
- You have accessRestricted accessAbstract 2834: Time to Adverse Events in REPLACE-2: Implications for Same-Day Discharge of PCI PatientsVivek Rajagopal, A. M Lincoff, Juhana Karha, Amy Hsu, Hitinder S Gurm and Eric J TopolCirculation. 2006;114:II_593
- You have accessRestricted accessAbstract 2651: Major Bleeding is Associated with Increased Short-Term Mortality and Ischemic Complications in Non-ST Elevation Acute Coronary Syndromes: The ACUITY TrialSteven V Manoukian, Michele D Voeltz, Frederick Feit, Ramin Ebrahimi, Roxana Mehran, Eugenia Nikolsky, Jeffrey W Moses, A M Lincoff, Spencer B King and Gregg W StoneCirculation. 2006;114:II_551-II_552
- You have accessAbstract 2651: Major Bleeding is Associated with Increased Short-Term Mortality and Ischemic Complications in Non-ST Elevation Acute Coronary Syndromes: The ACUITY TrialSteven V Manoukian, Michele D Voeltz, Frederick Feit, Ramin Ebrahimi, Roxana Mehran, Eugenia Nikolsky, Jeffrey W Moses, A M Lincoff, Spencer B King, Gregg W StoneCirculation October 2006, 114 (Suppl 18) II_551-II_552;By Steven V Manoukian, Michele D Voeltz, Frederick Feit, Ramin Ebrahimi, Roxana Mehran, Eugenia Nikolsky, Jeffrey W Moses, A M Lincoff, Spencer B King and Gregg W Stone
- You have accessRestricted accessAbstract 2648: Comparison of Heparin Plus IIb/IIIa Inhibition Versus Bivalirudin With or Without IIb/IIIa Inhibition in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The ACUITY TrialGregg W Stone, Harvey D White, E M Ohman, Michel E Bertrand, A M Lincoff, Brent T McLaurin, David A Cox, Stuart J Pocock, James H Ware, Frederick Feit, Antonio Colombo, Roxana Mehran and Jeffrey W MosesCirculation. 2006;114:II_551
- You have accessAbstract 2648: Comparison of Heparin Plus IIb/IIIa Inhibition Versus Bivalirudin With or Without IIb/IIIa Inhibition in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: The ACUITY TrialGregg W Stone, Harvey D White, E M Ohman, Michel E Bertrand, A M Lincoff, Brent T McLaurin, David A Cox, Stuart J Pocock, James H Ware, Frederick Feit, Antonio Colombo, Roxana Mehran, Jeffrey W MosesCirculation October 2006, 114 (Suppl 18) II_551;By Gregg W Stone, Harvey D White, E M Ohman, Michel E Bertrand, A M Lincoff, Brent T McLaurin, David A Cox, Stuart J Pocock, James H Ware, Frederick Feit, Antonio Colombo, Roxana Mehran and Jeffrey W Moses
- You have accessRestricted accessAbstract 14566: Mild Elevation in Cardiac Troponin T is Independently Associated With Long-Term Mortality After Intermediate or High-Risk Vascular SurgeryGrant W Reed, Samuel Horr, Stephen G Ellis, A. Michael Lincoff, Steven E Nissen and Venu MenonCirculation. 2015;132:A14566
Pages
Journal
Article Type
Article Type
- ACC/AHA Guideline Revision 2
- ACC/AHA Practice Guideline 1
- ACCF/AHA Focused Update 2
- ACCF/AHA Practice Guideline 58
- ACS: ECG, Angiography, Imaging-Diagnostic, Pathophysiologic, Prognostic Insights 2
- Acute Coronary Syndromes 14
- Acute Coronary Syndromes: Drug Therapies, Bleeding, and Outcomes 1
- Acute Coronary Syndromes: Insights into Risk and Treatment 2
- Acute coronary syndromes 5
- Advances in Antithrombotic Therapies in Acute Coronary Syndromes 1
- Aggregation 8
- Animal models of human disease 8
- Antiplatelets 5
- Antithrombin Therapy for ACS 2
- Arterial thrombosis 8
- Article 7
- Atherosclerosis, Vascular Biology and Development 1
- Basic Science Reports 2
- Brief Rapid Communications 3
- Cardiovascular Perspective 10
- Cardiovascular Pharmacology 4
- Catheter-Based Coronary Interventions: Stent Complications 2
- Catheter-Based Coronary Interventions: Stents: Registry Reports 1
- Catheter-Based Coronary Interventions: Stents: Safety Issues 1
- Catheter-based coronary interventions: stents 7
- Clinical Investigation and Reports 43
- Clinical Investigation and Reports* 1
- Clinical Science 20
- Contemporary STE and NSTE ACS Care 1
- Core 2. Epidemiology and Prevention of CV Disease: Physiology, Pharmacology and Lifestyle 1
- Core 2: Epidemiology and Prevention of CV Disease: Physiology, Pharmacology, and Lifestyle 2
- Core 6. Catheter-based and Surgical Interventions 1
- Core 7. Vascular Disease: Biology and Clinical Science 3
- Coronary Heart Disease 12
- Coronary Interventions 15
- Coronary Stent Thrombosis 2
- Correspondence 3
- Editorial 2
- Epidemiology and Prevention 1
- Featured Research: Thrombin Inhibition, Bleeding, and Outcomes in ACS 4
- Fibrinolysis 8
- Growth factors/cytokines 7
- Health policy and outcome research 5
- In Vitro 1
- Intervention and Surgery 1
- Interventional Cardiology 1
- Journal Article 2
- Lifestyle Factors 1
- New Drugs and Technologies 8
- Original Article 21
- Original Articles 19
- Original Articles Original Article Original Articles 8
- Original Articles Original Article Original Articles Coronary Interventions 7
- Original Research 11
- Original Research Article 10
- Other Vascular biology 7
- Other anticoagulants 5
- Percutaneous Coronary Intervention 6
- Platelet function inhibitors 4
- Platelets 8
- Poster 4
- Poster Session Title: Poster Session III 2
- Prognosis and Pharmacologic Therapy in ACS 1
- Research Support, Non-U.S. Gov't 1
- Research Support, U.S. Gov't, P.H.S. 1
- Review 2
- Risk Factor Interventions: Effects and Impact 2
- Secondary prevention 8
- Session Title: ACS and PCI: 30-Day Outcomes and Posthospitalization Care 1
- Session Title: CTOs, Left Mains, Bifurcations and Multivessel Disease 1
- Session Title: Diabetes Mellitus and CVD: Mechanistic Insights 1
- Session Title: HDL and the Artery Wall 1
- Session Title: Myocardial Protection, Intraoperative Management, and Postoperative Critical Care 1
- Session Title: Poster Session III 4
- Session Title: Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacologic Therapy-Focus on Patient Risk 1
- Session Title: Unstable Angina, NSTEMI and STEMI: Prognosis and Pharmacological Therapy 1
- Session Title: What's New in the Treatment of Patients with Acute Coronary Syndromes? 1
- Special Report 1
- Special Review 1
- Thrombosis 26
- Type 2 diabetes 14
- Vascular Biology 28
- Vascular Medicine 1
- Volume 126, Issue 21 Supplement; November 20, 2012 / Abstracts From the American Heart Association 2012 Scientific Sessions and Resuscitation Science Symposium 1
Subject
Subject
- AHA Statements and Guidelines 3
- Acute coronary syndromes 24
- Acute myocardial infarction 6
- Aggregation 16
- Animal models of human disease 17
- Anticoagulant mechanisms 9
- Antiplatelets 11
- Arrhythmias, clinical electrophysiology, drugs 1
- Arterial thrombosis 24
- CPR and emergency cardiac care 58
- CV surgery: coronary artery disease 1
- Cardiovascular Disease 11
- Cardiovascular Pharmacology 30
- Catheter-based coronary and valvular interventions: other 7
- Catheter-based coronary interventions: stents 27
- Chronic ischemic heart disease 11
- Coagulation 9
- Coagulation inhibitors 9
- Coronary imaging: angiography/ultrasound/Doppler/CC 2
- Epidemiology 1
- Fibrinolysis 16
- Growth factors/cytokines 14
- Health policy and outcome research 11
- Lipids and Cholesterol 10
- Mechanism of atherosclerosis/growth factors 1
- Mortality/Survival 11
- Other Treatment 1
- Other Vascular biology 14
- Other anticoagulants 18
- Other diabetes 2
- Other diagnostic testing 1
- Other heart failure 1
- Pathophysiology 1
- Platelet function inhibitors 18
- Platelets 26
- Quality and Outcomes 11
- Receptor pharmacology 1
- Restenosis 15
- Risk Factors for Stroke 1
- Secondary prevention 19
- Thrombin 8
- Type 2 diabetes 40
- Volume 126, Issue 21 Supplement; November 20, 2012 / Abstracts From the American Heart Association 2012 Scientific Sessions and Resuscitation Science Symposium 1
Content Type
Resource Type
- Articles 96
- Tables & Figures 136
- HWTABLE 65



